Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,024
archived clinical trials in
Infectious Disease

Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated:  12/31/1969
The Research Institute at Nationwide Children's Hospital
mi
from
Columbus, OH
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 12/31/1969
The Research Institute at Nationwide Children's Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated:  12/31/1969
Univ of Pennsylvania
mi
from
Philadelphia, PA
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 12/31/1969
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated:  12/31/1969
Brown University, Women & Infants Hospital of Rhode Island
mi
from
Providence, RI
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 12/31/1969
Brown University, Women & Infants Hospital of Rhode Island
mi
from
Providence, RI
Click here to add this to my saved trials
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated:  12/31/1969
UT Southwestern Medical Center
mi
from
Dallas, TX
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 12/31/1969
UT Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated:  12/31/1969
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 12/31/1969
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Click here to add this to my saved trials
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated:  12/31/1969
University of Utah
mi
from
Salt Lake City, UT
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 12/31/1969
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
ING200336, Pharmacokinetic and Safety Study in Pregnant Women With Human Immuno Virus Infection
ING200336: A Prospective, Interventional Pharmacokinetic and Safety Study of DTG/ABC/3TC in Pregnant Women
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Newark, NJ
ING200336, Pharmacokinetic and Safety Study in Pregnant Women With Human Immuno Virus Infection
ING200336: A Prospective, Interventional Pharmacokinetic and Safety Study of DTG/ABC/3TC in Pregnant Women
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Newark, NJ
Click here to add this to my saved trials
ING200336, Pharmacokinetic and Safety Study in Pregnant Women With Human Immuno Virus Infection
ING200336: A Prospective, Interventional Pharmacokinetic and Safety Study of DTG/ABC/3TC in Pregnant Women
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Bellaire, TX
ING200336, Pharmacokinetic and Safety Study in Pregnant Women With Human Immuno Virus Infection
ING200336: A Prospective, Interventional Pharmacokinetic and Safety Study of DTG/ABC/3TC in Pregnant Women
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Bellaire, TX
Click here to add this to my saved trials
ING200336, Pharmacokinetic and Safety Study in Pregnant Women With Human Immuno Virus Infection
ING200336: A Prospective, Interventional Pharmacokinetic and Safety Study of DTG/ABC/3TC in Pregnant Women
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Dallas, TX
ING200336, Pharmacokinetic and Safety Study in Pregnant Women With Human Immuno Virus Infection
ING200336: A Prospective, Interventional Pharmacokinetic and Safety Study of DTG/ABC/3TC in Pregnant Women
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Dallas, TX
Click here to add this to my saved trials
ING200336, Pharmacokinetic and Safety Study in Pregnant Women With Human Immuno Virus Infection
ING200336: A Prospective, Interventional Pharmacokinetic and Safety Study of DTG/ABC/3TC in Pregnant Women
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Orel,
ING200336, Pharmacokinetic and Safety Study in Pregnant Women With Human Immuno Virus Infection
ING200336: A Prospective, Interventional Pharmacokinetic and Safety Study of DTG/ABC/3TC in Pregnant Women
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Orel,
Click here to add this to my saved trials
Fresh Versus Frozen Stool for Fecal Transplant in Children
A Comparison of Efficacy of Fresh Versus Frozen Donor Stool for Fecal Microbial Transplant in Children With Recurrent Clostridium Difficile Infections
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic Rochester
mi
from
Rochester, MN
Fresh Versus Frozen Stool for Fecal Transplant in Children
A Comparison of Efficacy of Fresh Versus Frozen Donor Stool for Fecal Microbial Transplant in Children With Recurrent Clostridium Difficile Infections
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Study of Debio 1450 for Bacterial Skin Infections
A Phase 2, Randomized, Double-Blind, Multicenter Study of Safety, Tolerability, and Efficacy of Debio 1450 vs Vancomycin (IV)/Linezolid (Oral) in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Due to Staphylococcus Sensitive or Resistant to Methicillin
Status: Enrolling
Updated:  12/31/1969
Dream Team Clinical Research
mi
from
Anaheim, CA
Study of Debio 1450 for Bacterial Skin Infections
A Phase 2, Randomized, Double-Blind, Multicenter Study of Safety, Tolerability, and Efficacy of Debio 1450 vs Vancomycin (IV)/Linezolid (Oral) in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Due to Staphylococcus Sensitive or Resistant to Methicillin
Status: Enrolling
Updated: 12/31/1969
Dream Team Clinical Research
mi
from
Anaheim, CA
Click here to add this to my saved trials
Study of Debio 1450 for Bacterial Skin Infections
A Phase 2, Randomized, Double-Blind, Multicenter Study of Safety, Tolerability, and Efficacy of Debio 1450 vs Vancomycin (IV)/Linezolid (Oral) in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Due to Staphylococcus Sensitive or Resistant to Methicillin
Status: Enrolling
Updated:  12/31/1969
Physician Alliance Research Center
mi
from
Anaheim, CA
Study of Debio 1450 for Bacterial Skin Infections
A Phase 2, Randomized, Double-Blind, Multicenter Study of Safety, Tolerability, and Efficacy of Debio 1450 vs Vancomycin (IV)/Linezolid (Oral) in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Due to Staphylococcus Sensitive or Resistant to Methicillin
Status: Enrolling
Updated: 12/31/1969
Physician Alliance Research Center
mi
from
Anaheim, CA
Click here to add this to my saved trials
Study of Debio 1450 for Bacterial Skin Infections
A Phase 2, Randomized, Double-Blind, Multicenter Study of Safety, Tolerability, and Efficacy of Debio 1450 vs Vancomycin (IV)/Linezolid (Oral) in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Due to Staphylococcus Sensitive or Resistant to Methicillin
Status: Enrolling
Updated:  12/31/1969
Southbay Pharma Research
mi
from
Buena Park, CA
Study of Debio 1450 for Bacterial Skin Infections
A Phase 2, Randomized, Double-Blind, Multicenter Study of Safety, Tolerability, and Efficacy of Debio 1450 vs Vancomycin (IV)/Linezolid (Oral) in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Due to Staphylococcus Sensitive or Resistant to Methicillin
Status: Enrolling
Updated: 12/31/1969
Southbay Pharma Research
mi
from
Buena Park, CA
Click here to add this to my saved trials
Study of Debio 1450 for Bacterial Skin Infections
A Phase 2, Randomized, Double-Blind, Multicenter Study of Safety, Tolerability, and Efficacy of Debio 1450 vs Vancomycin (IV)/Linezolid (Oral) in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Due to Staphylococcus Sensitive or Resistant to Methicillin
Status: Enrolling
Updated:  12/31/1969
eStudySite - Chula Vista
mi
from
Chula Vista, CA
Study of Debio 1450 for Bacterial Skin Infections
A Phase 2, Randomized, Double-Blind, Multicenter Study of Safety, Tolerability, and Efficacy of Debio 1450 vs Vancomycin (IV)/Linezolid (Oral) in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Due to Staphylococcus Sensitive or Resistant to Methicillin
Status: Enrolling
Updated: 12/31/1969
eStudySite - Chula Vista
mi
from
Chula Vista, CA
Click here to add this to my saved trials
Study of Debio 1450 for Bacterial Skin Infections
A Phase 2, Randomized, Double-Blind, Multicenter Study of Safety, Tolerability, and Efficacy of Debio 1450 vs Vancomycin (IV)/Linezolid (Oral) in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Due to Staphylococcus Sensitive or Resistant to Methicillin
Status: Enrolling
Updated:  12/31/1969
eStudySite, La Mesa
mi
from
La Mesa, CA
Study of Debio 1450 for Bacterial Skin Infections
A Phase 2, Randomized, Double-Blind, Multicenter Study of Safety, Tolerability, and Efficacy of Debio 1450 vs Vancomycin (IV)/Linezolid (Oral) in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Due to Staphylococcus Sensitive or Resistant to Methicillin
Status: Enrolling
Updated: 12/31/1969
eStudySite, La Mesa
mi
from
La Mesa, CA
Click here to add this to my saved trials
Study of Debio 1450 for Bacterial Skin Infections
A Phase 2, Randomized, Double-Blind, Multicenter Study of Safety, Tolerability, and Efficacy of Debio 1450 vs Vancomycin (IV)/Linezolid (Oral) in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Due to Staphylococcus Sensitive or Resistant to Methicillin
Status: Enrolling
Updated:  12/31/1969
Long Beach Clinical Trials
mi
from
Long Beach, CA
Study of Debio 1450 for Bacterial Skin Infections
A Phase 2, Randomized, Double-Blind, Multicenter Study of Safety, Tolerability, and Efficacy of Debio 1450 vs Vancomycin (IV)/Linezolid (Oral) in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Due to Staphylococcus Sensitive or Resistant to Methicillin
Status: Enrolling
Updated: 12/31/1969
Long Beach Clinical Trials
mi
from
Long Beach, CA
Click here to add this to my saved trials
Study of Debio 1450 for Bacterial Skin Infections
A Phase 2, Randomized, Double-Blind, Multicenter Study of Safety, Tolerability, and Efficacy of Debio 1450 vs Vancomycin (IV)/Linezolid (Oral) in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Due to Staphylococcus Sensitive or Resistant to Methicillin
Status: Enrolling
Updated:  12/31/1969
Alliance Research
mi
from
Long Beach, CA
Study of Debio 1450 for Bacterial Skin Infections
A Phase 2, Randomized, Double-Blind, Multicenter Study of Safety, Tolerability, and Efficacy of Debio 1450 vs Vancomycin (IV)/Linezolid (Oral) in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Due to Staphylococcus Sensitive or Resistant to Methicillin
Status: Enrolling
Updated: 12/31/1969
Alliance Research
mi
from
Long Beach, CA
Click here to add this to my saved trials
Study of Debio 1450 for Bacterial Skin Infections
A Phase 2, Randomized, Double-Blind, Multicenter Study of Safety, Tolerability, and Efficacy of Debio 1450 vs Vancomycin (IV)/Linezolid (Oral) in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Due to Staphylococcus Sensitive or Resistant to Methicillin
Status: Enrolling
Updated:  12/31/1969
Central Valley Research, LLC
mi
from
Modesto, CA
Study of Debio 1450 for Bacterial Skin Infections
A Phase 2, Randomized, Double-Blind, Multicenter Study of Safety, Tolerability, and Efficacy of Debio 1450 vs Vancomycin (IV)/Linezolid (Oral) in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Due to Staphylococcus Sensitive or Resistant to Methicillin
Status: Enrolling
Updated: 12/31/1969
Central Valley Research, LLC
mi
from
Modesto, CA
Click here to add this to my saved trials
Study of Debio 1450 for Bacterial Skin Infections
A Phase 2, Randomized, Double-Blind, Multicenter Study of Safety, Tolerability, and Efficacy of Debio 1450 vs Vancomycin (IV)/Linezolid (Oral) in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Due to Staphylococcus Sensitive or Resistant to Methicillin
Status: Enrolling
Updated:  12/31/1969
eStudySite - Oceanside
mi
from
Oceanside, CA
Study of Debio 1450 for Bacterial Skin Infections
A Phase 2, Randomized, Double-Blind, Multicenter Study of Safety, Tolerability, and Efficacy of Debio 1450 vs Vancomycin (IV)/Linezolid (Oral) in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Due to Staphylococcus Sensitive or Resistant to Methicillin
Status: Enrolling
Updated: 12/31/1969
eStudySite - Oceanside
mi
from
Oceanside, CA
Click here to add this to my saved trials
Study of Debio 1450 for Bacterial Skin Infections
A Phase 2, Randomized, Double-Blind, Multicenter Study of Safety, Tolerability, and Efficacy of Debio 1450 vs Vancomycin (IV)/Linezolid (Oral) in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Due to Staphylococcus Sensitive or Resistant to Methicillin
Status: Enrolling
Updated:  12/31/1969
Olive View - UCLA Medical Center
mi
from
Sylmar, CA
Study of Debio 1450 for Bacterial Skin Infections
A Phase 2, Randomized, Double-Blind, Multicenter Study of Safety, Tolerability, and Efficacy of Debio 1450 vs Vancomycin (IV)/Linezolid (Oral) in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Due to Staphylococcus Sensitive or Resistant to Methicillin
Status: Enrolling
Updated: 12/31/1969
Olive View - UCLA Medical Center
mi
from
Sylmar, CA
Click here to add this to my saved trials
Study of Debio 1450 for Bacterial Skin Infections
A Phase 2, Randomized, Double-Blind, Multicenter Study of Safety, Tolerability, and Efficacy of Debio 1450 vs Vancomycin (IV)/Linezolid (Oral) in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Due to Staphylococcus Sensitive or Resistant to Methicillin
Status: Enrolling
Updated:  12/31/1969
Shands Burn Center at University of Florida
mi
from
Gainesville, FL
Study of Debio 1450 for Bacterial Skin Infections
A Phase 2, Randomized, Double-Blind, Multicenter Study of Safety, Tolerability, and Efficacy of Debio 1450 vs Vancomycin (IV)/Linezolid (Oral) in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Due to Staphylococcus Sensitive or Resistant to Methicillin
Status: Enrolling
Updated: 12/31/1969
Shands Burn Center at University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
Study of Debio 1450 for Bacterial Skin Infections
A Phase 2, Randomized, Double-Blind, Multicenter Study of Safety, Tolerability, and Efficacy of Debio 1450 vs Vancomycin (IV)/Linezolid (Oral) in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Due to Staphylococcus Sensitive or Resistant to Methicillin
Status: Enrolling
Updated:  12/31/1969
Central Florida Internists
mi
from
Orlando, FL
Study of Debio 1450 for Bacterial Skin Infections
A Phase 2, Randomized, Double-Blind, Multicenter Study of Safety, Tolerability, and Efficacy of Debio 1450 vs Vancomycin (IV)/Linezolid (Oral) in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Due to Staphylococcus Sensitive or Resistant to Methicillin
Status: Enrolling
Updated: 12/31/1969
Central Florida Internists
mi
from
Orlando, FL
Click here to add this to my saved trials
Study of Debio 1450 for Bacterial Skin Infections
A Phase 2, Randomized, Double-Blind, Multicenter Study of Safety, Tolerability, and Efficacy of Debio 1450 vs Vancomycin (IV)/Linezolid (Oral) in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Due to Staphylococcus Sensitive or Resistant to Methicillin
Status: Enrolling
Updated:  12/31/1969
Triple O Research Institute, P.A.
mi
from
West Palm Beach, FL
Study of Debio 1450 for Bacterial Skin Infections
A Phase 2, Randomized, Double-Blind, Multicenter Study of Safety, Tolerability, and Efficacy of Debio 1450 vs Vancomycin (IV)/Linezolid (Oral) in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Due to Staphylococcus Sensitive or Resistant to Methicillin
Status: Enrolling
Updated: 12/31/1969
Triple O Research Institute, P.A.
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
Study of Debio 1450 for Bacterial Skin Infections
A Phase 2, Randomized, Double-Blind, Multicenter Study of Safety, Tolerability, and Efficacy of Debio 1450 vs Vancomycin (IV)/Linezolid (Oral) in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Due to Staphylococcus Sensitive or Resistant to Methicillin
Status: Enrolling
Updated:  12/31/1969
Columbus Regional Research
mi
from
Columbus, GA
Study of Debio 1450 for Bacterial Skin Infections
A Phase 2, Randomized, Double-Blind, Multicenter Study of Safety, Tolerability, and Efficacy of Debio 1450 vs Vancomycin (IV)/Linezolid (Oral) in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Due to Staphylococcus Sensitive or Resistant to Methicillin
Status: Enrolling
Updated: 12/31/1969
Columbus Regional Research
mi
from
Columbus, GA
Click here to add this to my saved trials
Study of Debio 1450 for Bacterial Skin Infections
A Phase 2, Randomized, Double-Blind, Multicenter Study of Safety, Tolerability, and Efficacy of Debio 1450 vs Vancomycin (IV)/Linezolid (Oral) in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Due to Staphylococcus Sensitive or Resistant to Methicillin
Status: Enrolling
Updated:  12/31/1969
Beaumont Infectious Disease Services
mi
from
Royal Oak, MI
Study of Debio 1450 for Bacterial Skin Infections
A Phase 2, Randomized, Double-Blind, Multicenter Study of Safety, Tolerability, and Efficacy of Debio 1450 vs Vancomycin (IV)/Linezolid (Oral) in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Due to Staphylococcus Sensitive or Resistant to Methicillin
Status: Enrolling
Updated: 12/31/1969
Beaumont Infectious Disease Services
mi
from
Royal Oak, MI
Click here to add this to my saved trials
Study of Debio 1450 for Bacterial Skin Infections
A Phase 2, Randomized, Double-Blind, Multicenter Study of Safety, Tolerability, and Efficacy of Debio 1450 vs Vancomycin (IV)/Linezolid (Oral) in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Due to Staphylococcus Sensitive or Resistant to Methicillin
Status: Enrolling
Updated:  12/31/1969
Mercury Street Medical Group, Pllc
mi
from
Butte, MT
Study of Debio 1450 for Bacterial Skin Infections
A Phase 2, Randomized, Double-Blind, Multicenter Study of Safety, Tolerability, and Efficacy of Debio 1450 vs Vancomycin (IV)/Linezolid (Oral) in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Due to Staphylococcus Sensitive or Resistant to Methicillin
Status: Enrolling
Updated: 12/31/1969
Mercury Street Medical Group, Pllc
mi
from
Butte, MT
Click here to add this to my saved trials
Study of Debio 1450 for Bacterial Skin Infections
A Phase 2, Randomized, Double-Blind, Multicenter Study of Safety, Tolerability, and Efficacy of Debio 1450 vs Vancomycin (IV)/Linezolid (Oral) in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Due to Staphylococcus Sensitive or Resistant to Methicillin
Status: Enrolling
Updated:  12/31/1969
eStudySite - Las Vegas
mi
from
Las Vegas, NV
Study of Debio 1450 for Bacterial Skin Infections
A Phase 2, Randomized, Double-Blind, Multicenter Study of Safety, Tolerability, and Efficacy of Debio 1450 vs Vancomycin (IV)/Linezolid (Oral) in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Due to Staphylococcus Sensitive or Resistant to Methicillin
Status: Enrolling
Updated: 12/31/1969
eStudySite - Las Vegas
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Study of Debio 1450 for Bacterial Skin Infections
A Phase 2, Randomized, Double-Blind, Multicenter Study of Safety, Tolerability, and Efficacy of Debio 1450 vs Vancomycin (IV)/Linezolid (Oral) in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Due to Staphylococcus Sensitive or Resistant to Methicillin
Status: Enrolling
Updated:  12/31/1969
South Jersey Infectious Disease
mi
from
Somers Point, NJ
Study of Debio 1450 for Bacterial Skin Infections
A Phase 2, Randomized, Double-Blind, Multicenter Study of Safety, Tolerability, and Efficacy of Debio 1450 vs Vancomycin (IV)/Linezolid (Oral) in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Due to Staphylococcus Sensitive or Resistant to Methicillin
Status: Enrolling
Updated: 12/31/1969
South Jersey Infectious Disease
mi
from
Somers Point, NJ
Click here to add this to my saved trials
Study of Debio 1450 for Bacterial Skin Infections
A Phase 2, Randomized, Double-Blind, Multicenter Study of Safety, Tolerability, and Efficacy of Debio 1450 vs Vancomycin (IV)/Linezolid (Oral) in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Due to Staphylococcus Sensitive or Resistant to Methicillin
Status: Enrolling
Updated:  12/31/1969
Holy Name Medical Center
mi
from
Teaneck, NJ
Study of Debio 1450 for Bacterial Skin Infections
A Phase 2, Randomized, Double-Blind, Multicenter Study of Safety, Tolerability, and Efficacy of Debio 1450 vs Vancomycin (IV)/Linezolid (Oral) in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Due to Staphylococcus Sensitive or Resistant to Methicillin
Status: Enrolling
Updated: 12/31/1969
Holy Name Medical Center
mi
from
Teaneck, NJ
Click here to add this to my saved trials
Study of Debio 1450 for Bacterial Skin Infections
A Phase 2, Randomized, Double-Blind, Multicenter Study of Safety, Tolerability, and Efficacy of Debio 1450 vs Vancomycin (IV)/Linezolid (Oral) in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Due to Staphylococcus Sensitive or Resistant to Methicillin
Status: Enrolling
Updated:  12/31/1969
ID Clinical Research, Ltd.
mi
from
Toledo, OH
Study of Debio 1450 for Bacterial Skin Infections
A Phase 2, Randomized, Double-Blind, Multicenter Study of Safety, Tolerability, and Efficacy of Debio 1450 vs Vancomycin (IV)/Linezolid (Oral) in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Due to Staphylococcus Sensitive or Resistant to Methicillin
Status: Enrolling
Updated: 12/31/1969
ID Clinical Research, Ltd.
mi
from
Toledo, OH
Click here to add this to my saved trials
Study of Debio 1450 for Bacterial Skin Infections
A Phase 2, Randomized, Double-Blind, Multicenter Study of Safety, Tolerability, and Efficacy of Debio 1450 vs Vancomycin (IV)/Linezolid (Oral) in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Due to Staphylococcus Sensitive or Resistant to Methicillin
Status: Enrolling
Updated:  12/31/1969
East Montgomery County Clinic
mi
from
Houston, TX
Study of Debio 1450 for Bacterial Skin Infections
A Phase 2, Randomized, Double-Blind, Multicenter Study of Safety, Tolerability, and Efficacy of Debio 1450 vs Vancomycin (IV)/Linezolid (Oral) in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Due to Staphylococcus Sensitive or Resistant to Methicillin
Status: Enrolling
Updated: 12/31/1969
East Montgomery County Clinic
mi
from
Houston, TX
Click here to add this to my saved trials
Study of Debio 1450 for Bacterial Skin Infections
A Phase 2, Randomized, Double-Blind, Multicenter Study of Safety, Tolerability, and Efficacy of Debio 1450 vs Vancomycin (IV)/Linezolid (Oral) in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Due to Staphylococcus Sensitive or Resistant to Methicillin
Status: Enrolling
Updated:  12/31/1969
Tidwell Medical Center
mi
from
Splendora, TX
Study of Debio 1450 for Bacterial Skin Infections
A Phase 2, Randomized, Double-Blind, Multicenter Study of Safety, Tolerability, and Efficacy of Debio 1450 vs Vancomycin (IV)/Linezolid (Oral) in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Due to Staphylococcus Sensitive or Resistant to Methicillin
Status: Enrolling
Updated: 12/31/1969
Tidwell Medical Center
mi
from
Splendora, TX
Click here to add this to my saved trials
Micronized dHACM Injectable for the Treatment of Plantar Fasciitis
A Prospective, Single-Blinded, Randomized Controlled Trial of the Micronized dHACM Injection as Compared to the Saline Placebo Injection in the Treatment of Plantar Fasciitis
Status: Enrolling
Updated:  12/31/1969
Limb Preservation Platform
mi
from
Fresno, CA
Micronized dHACM Injectable for the Treatment of Plantar Fasciitis
A Prospective, Single-Blinded, Randomized Controlled Trial of the Micronized dHACM Injection as Compared to the Saline Placebo Injection in the Treatment of Plantar Fasciitis
Status: Enrolling
Updated: 12/31/1969
Limb Preservation Platform
mi
from
Fresno, CA
Click here to add this to my saved trials
Micronized dHACM Injectable for the Treatment of Plantar Fasciitis
A Prospective, Single-Blinded, Randomized Controlled Trial of the Micronized dHACM Injection as Compared to the Saline Placebo Injection in the Treatment of Plantar Fasciitis
Status: Enrolling
Updated:  12/31/1969
Center For Clinical Research Inc.
mi
from
San Francisco, CA
Micronized dHACM Injectable for the Treatment of Plantar Fasciitis
A Prospective, Single-Blinded, Randomized Controlled Trial of the Micronized dHACM Injection as Compared to the Saline Placebo Injection in the Treatment of Plantar Fasciitis
Status: Enrolling
Updated: 12/31/1969
Center For Clinical Research Inc.
mi
from
San Francisco, CA
Click here to add this to my saved trials
Micronized dHACM Injectable for the Treatment of Plantar Fasciitis
A Prospective, Single-Blinded, Randomized Controlled Trial of the Micronized dHACM Injection as Compared to the Saline Placebo Injection in the Treatment of Plantar Fasciitis
Status: Enrolling
Updated:  12/31/1969
Orlando VA Healthcare System
mi
from
Orlando, FL
Micronized dHACM Injectable for the Treatment of Plantar Fasciitis
A Prospective, Single-Blinded, Randomized Controlled Trial of the Micronized dHACM Injection as Compared to the Saline Placebo Injection in the Treatment of Plantar Fasciitis
Status: Enrolling
Updated: 12/31/1969
Orlando VA Healthcare System
mi
from
Orlando, FL
Click here to add this to my saved trials
Micronized dHACM Injectable for the Treatment of Plantar Fasciitis
A Prospective, Single-Blinded, Randomized Controlled Trial of the Micronized dHACM Injection as Compared to the Saline Placebo Injection in the Treatment of Plantar Fasciitis
Status: Enrolling
Updated:  12/31/1969
Timonium Foot and Ankle Center
mi
from
Baltimore, MD
Micronized dHACM Injectable for the Treatment of Plantar Fasciitis
A Prospective, Single-Blinded, Randomized Controlled Trial of the Micronized dHACM Injection as Compared to the Saline Placebo Injection in the Treatment of Plantar Fasciitis
Status: Enrolling
Updated: 12/31/1969
Timonium Foot and Ankle Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Micronized dHACM Injectable for the Treatment of Plantar Fasciitis
A Prospective, Single-Blinded, Randomized Controlled Trial of the Micronized dHACM Injection as Compared to the Saline Placebo Injection in the Treatment of Plantar Fasciitis
Status: Enrolling
Updated:  12/31/1969
MedStar Union Memorial Hospital
mi
from
Baltimore, MD
Micronized dHACM Injectable for the Treatment of Plantar Fasciitis
A Prospective, Single-Blinded, Randomized Controlled Trial of the Micronized dHACM Injection as Compared to the Saline Placebo Injection in the Treatment of Plantar Fasciitis
Status: Enrolling
Updated: 12/31/1969
MedStar Union Memorial Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
Micronized dHACM Injectable for the Treatment of Plantar Fasciitis
A Prospective, Single-Blinded, Randomized Controlled Trial of the Micronized dHACM Injection as Compared to the Saline Placebo Injection in the Treatment of Plantar Fasciitis
Status: Enrolling
Updated:  12/31/1969
Scott and White Healthcare
mi
from
Temple, TX
Micronized dHACM Injectable for the Treatment of Plantar Fasciitis
A Prospective, Single-Blinded, Randomized Controlled Trial of the Micronized dHACM Injection as Compared to the Saline Placebo Injection in the Treatment of Plantar Fasciitis
Status: Enrolling
Updated: 12/31/1969
Scott and White Healthcare
mi
from
Temple, TX
Click here to add this to my saved trials
Micronized dHACM Injectable for the Treatment of Plantar Fasciitis
A Prospective, Single-Blinded, Randomized Controlled Trial of the Micronized dHACM Injection as Compared to the Saline Placebo Injection in the Treatment of Plantar Fasciitis
Status: Enrolling
Updated:  12/31/1969
Coastal Podiatry Group
mi
from
Virginia Beach, VA
Micronized dHACM Injectable for the Treatment of Plantar Fasciitis
A Prospective, Single-Blinded, Randomized Controlled Trial of the Micronized dHACM Injection as Compared to the Saline Placebo Injection in the Treatment of Plantar Fasciitis
Status: Enrolling
Updated: 12/31/1969
Coastal Podiatry Group
mi
from
Virginia Beach, VA
Click here to add this to my saved trials
Micronized dHACM Injectable for the Treatment of Plantar Fasciitis
A Prospective, Single-Blinded, Randomized Controlled Trial of the Micronized dHACM Injection as Compared to the Saline Placebo Injection in the Treatment of Plantar Fasciitis
Status: Enrolling
Updated:  12/31/1969
Southern Arizona VA Health Care System
mi
from
Tucson, AZ
Micronized dHACM Injectable for the Treatment of Plantar Fasciitis
A Prospective, Single-Blinded, Randomized Controlled Trial of the Micronized dHACM Injection as Compared to the Saline Placebo Injection in the Treatment of Plantar Fasciitis
Status: Enrolling
Updated: 12/31/1969
Southern Arizona VA Health Care System
mi
from
Tucson, AZ
Click here to add this to my saved trials
Micronized dHACM Injectable for the Treatment of Plantar Fasciitis
A Prospective, Single-Blinded, Randomized Controlled Trial of the Micronized dHACM Injection as Compared to the Saline Placebo Injection in the Treatment of Plantar Fasciitis
Status: Enrolling
Updated:  12/31/1969
James A Lovell Federal Health Care Center
mi
from
North Chicago, IL
Micronized dHACM Injectable for the Treatment of Plantar Fasciitis
A Prospective, Single-Blinded, Randomized Controlled Trial of the Micronized dHACM Injection as Compared to the Saline Placebo Injection in the Treatment of Plantar Fasciitis
Status: Enrolling
Updated: 12/31/1969
James A Lovell Federal Health Care Center
mi
from
North Chicago, IL
Click here to add this to my saved trials
Micronized dHACM Injectable for the Treatment of Plantar Fasciitis
A Prospective, Single-Blinded, Randomized Controlled Trial of the Micronized dHACM Injection as Compared to the Saline Placebo Injection in the Treatment of Plantar Fasciitis
Status: Enrolling
Updated:  12/31/1969
Edward Hines Jr. Veterans Administration Hospital
mi
from
Chicago, IL
Micronized dHACM Injectable for the Treatment of Plantar Fasciitis
A Prospective, Single-Blinded, Randomized Controlled Trial of the Micronized dHACM Injection as Compared to the Saline Placebo Injection in the Treatment of Plantar Fasciitis
Status: Enrolling
Updated: 12/31/1969
Edward Hines Jr. Veterans Administration Hospital
mi
from
Chicago, IL
Click here to add this to my saved trials
Outcomes in Liver Disease Patient With and Without HIV Co-infection-Sub Study 2: HCV Treatment: Health Related Quality
Outcomes in Liver Disease Patient With and Without HIV Co-infection-Sub Study 2: HCV Treatment: Health Related Quality of Life, Fatigue, Work Productivity, Liver Status and Cost-per-SVR/Health Care Utilization
Status: Enrolling
Updated:  12/31/1969
Icahn School of Medicine
mi
from
New York, NY
Outcomes in Liver Disease Patient With and Without HIV Co-infection-Sub Study 2: HCV Treatment: Health Related Quality
Outcomes in Liver Disease Patient With and Without HIV Co-infection-Sub Study 2: HCV Treatment: Health Related Quality of Life, Fatigue, Work Productivity, Liver Status and Cost-per-SVR/Health Care Utilization
Status: Enrolling
Updated: 12/31/1969
Icahn School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics and Safety of Subgam-VF in Primary Immunodeficiency Diseases
Status: Enrolling
Updated:  12/31/1969
Arizona Allergy Associates
mi
from
Chandler, AZ
Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics and Safety of Subgam-VF in Primary Immunodeficiency Diseases
Status: Enrolling
Updated: 12/31/1969
Arizona Allergy Associates
mi
from
Chandler, AZ
Click here to add this to my saved trials
Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics and Safety of Subgam-VF in Primary Immunodeficiency Diseases
Status: Enrolling
Updated:  12/31/1969
University of California, Irvine
mi
from
Irvine, CA
Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics and Safety of Subgam-VF in Primary Immunodeficiency Diseases
Status: Enrolling
Updated: 12/31/1969
University of California, Irvine
mi
from
Irvine, CA
Click here to add this to my saved trials
Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics and Safety of Subgam-VF in Primary Immunodeficiency Diseases
Status: Enrolling
Updated:  12/31/1969
University California San Diego - Rady's Children's Hospital
mi
from
San Diego, CA
Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics and Safety of Subgam-VF in Primary Immunodeficiency Diseases
Status: Enrolling
Updated: 12/31/1969
University California San Diego - Rady's Children's Hospital
mi
from
San Diego, CA
Click here to add this to my saved trials
Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics and Safety of Subgam-VF in Primary Immunodeficiency Diseases
Status: Enrolling
Updated:  12/31/1969
Immunoe International Research
mi
from
Centennial, CO
Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics and Safety of Subgam-VF in Primary Immunodeficiency Diseases
Status: Enrolling
Updated: 12/31/1969
Immunoe International Research
mi
from
Centennial, CO
Click here to add this to my saved trials
Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics and Safety of Subgam-VF in Primary Immunodeficiency Diseases
Status: Enrolling
Updated:  12/31/1969
Allergy Associate of the Palm Beaches
mi
from
North Palm Beach, FL
Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics and Safety of Subgam-VF in Primary Immunodeficiency Diseases
Status: Enrolling
Updated: 12/31/1969
Allergy Associate of the Palm Beaches
mi
from
North Palm Beach, FL
Click here to add this to my saved trials
Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics and Safety of Subgam-VF in Primary Immunodeficiency Diseases
Status: Enrolling
Updated:  12/31/1969
Ann and Robert H. Lurie Children's Hospital
mi
from
Chicago, IL
Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics and Safety of Subgam-VF in Primary Immunodeficiency Diseases
Status: Enrolling
Updated: 12/31/1969
Ann and Robert H. Lurie Children's Hospital
mi
from
Chicago, IL
Click here to add this to my saved trials